Search research articles
Contact Us
Filters
Showing results (251-260 of 424) with videos related to
Page
of 43
Sort By:
Thrombosis and Haemostasis
|
April 12, 1990
Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency
M Wolf, C Boyer-Neumann, P Molho-Sabatier, et al.
Revue Des Maladies Respiratoires
|
October 17, 2016
[Which treatments for the hyperventilation syndrome in adults?]
A Rapin, G Deslee, L Percebois-Macadre, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
November 20, 1998
Renal vascular Doppler imaging: clinical benefits of power mode
O Hélénon, J M Correas, J Chabriais, et al.
The Journal of Clinical Psychiatry
|
June 10, 2000
Patients with schizophrenia at risk for excessive antipsychotic dosing
J T Walkup, D D McAlpine, M Olfson, et al.
Blood
|
March 7, 1998
Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases
E Fressinaud, A Veyradier, F Truchaud, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 1, 1993
The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin
P Grailhe, C Boyer-Neumann, F Haverkate, et al.
European Journal of Immunology
|
August 1, 1985
Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability
M Takiguchi, J P Ting, S C Buessow, et al.
Pacing and Clinical Electrophysiology : PACE
|
March 1, 1979
Long-term results of permanent atrioventricular sequential demand pacing
S Levy, R Gerard, J M Jausseran, et al.
The European Respiratory Journal
|
March 8, 2000
Thrombotic risk factors in pulmonary hypertension
M Wolf, C Boyer-Neumann, F Parent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression
F Xu, Y Yu, X F Le, et al.
Page
of 43
Search research articles
Search
Showing results (251-260 of 424) with videos related to
Sort By:
Page
of 43
Thrombosis and Haemostasis
|
April 12, 1990
Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency
M Wolf, C Boyer-Neumann, P Molho-Sabatier, et al.
Revue Des Maladies Respiratoires
|
October 17, 2016
[Which treatments for the hyperventilation syndrome in adults?]
A Rapin, G Deslee, L Percebois-Macadre, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
November 20, 1998
Renal vascular Doppler imaging: clinical benefits of power mode
O Hélénon, J M Correas, J Chabriais, et al.
The Journal of Clinical Psychiatry
|
June 10, 2000
Patients with schizophrenia at risk for excessive antipsychotic dosing
J T Walkup, D D McAlpine, M Olfson, et al.
Blood
|
March 7, 1998
Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases
E Fressinaud, A Veyradier, F Truchaud, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 1, 1993
The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin
P Grailhe, C Boyer-Neumann, F Haverkate, et al.
European Journal of Immunology
|
August 1, 1985
Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability
M Takiguchi, J P Ting, S C Buessow, et al.
Pacing and Clinical Electrophysiology : PACE
|
March 1, 1979
Long-term results of permanent atrioventricular sequential demand pacing
S Levy, R Gerard, J M Jausseran, et al.
The European Respiratory Journal
|
March 8, 2000
Thrombotic risk factors in pulmonary hypertension
M Wolf, C Boyer-Neumann, F Parent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 1999
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression
F Xu, Y Yu, X F Le, et al.
Page
of 43